Intuitive Surgical Inc (ISRG) Cash Flow Statement
A cash flow statement shows the actual cash a company generated and spent across operating, investing, and financing activities over a reporting period.
Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally.
Total Cash From Operating Activities Chart for Intuitive Surgical Inc
Intuitive Surgical Inc (ISRG) operating cash flow for FY2025 was USD 3.0B, a 25.5% change from FY2024. Intuitive Surgical Inc's operating cash flow moved from USD -15.9M in 1999 to USD 3.0B in 2025 over 26 years. Operating cash flow compound annual growth rate: 5-year CAGR of 15.3%, 10-year CAGR of 14.7%, 20-year CAGR of 20.7%.
Total Cash From Operating Activities (US Dollars)
R&D as % of Revenue
Compare with
Key Stats
- Market Cap
- $133.89B
- Implied Share Price
- $373.71
- Enterprise Value
- $124.88B
- Revenue (TTM)
- $11.03B
- EBITDA
- $4.18B
- Profit Margin
- 28.45%
- Trailing P/E
- 43.10
- Forward P/E
- 34.13
- Price/Book (MRQ)
- 7.16
- Price/Sales (TTM)
- 12.13
- EV/EBITDA
- 29.42
- EV/Revenue
- 11.32
- Dividend Yield
- —
- Book Value
- $51.34
- Free Cash Flow (FY2025)
- $2.49B
- Free Cash Flow Yield
- 1.86%
Snapshot as of 7th August 2026 — not point-in-time controlled, may lag the live market by a few days.